×
Download 2025 Brochure

2025 Conference Programs


Register Early for Maximum Savings
View Programs
Sponsorship Opportunities
Present a Poster - Posters Info

Video Highlights

TRI-CON 2025: Over 30 Years of Driving Innovation and Collaboration in Diagnostics and Precision Medicine

For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join over a thousand international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and artificial intelligence; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2025. The new track on precision medicine beyond oncology will cover applications in immunology, neurology, and metabolic diseases. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you’ve come to expect from the TRI-CON!



2025 Featured Speakers

Mara Aspinall

Mara Aspinall
Partner
Illumina Ventures

Peter Foley

Peter Foley
CEO
LetsGetChecked

Lisa Alderson

Lisa Alderson
CEO
Adela

Gabriele Allegri

Gabriele Allegri
VP, Global Commercial Precision Medicine
Johnson & Johnson

Alex Aravanis

Alex Aravanis
CEO
Moonwalk Biosciences

Omar Perez

Omar Perez
Head of Medical Diagnostics
AstraZeneca

Jenny Rooke

Jenny Rooke
Managing Director
Genoa Ventures

Ajit Singh

Ajit Singh
Partner
Artiman Ventures

Susan Tousi

Susan Tousi
CEO
DELFI Diagnostics

Sonya Makhni

Steffan Ho
VP, Translational Oncology
Pfizer

Lourdes Barrera

Lourdes Barrera
Executive Director, Precision Medicine
Merck

Christopher Conn

Christopher Conn
Director, Diagnostics Strategy
Amgen

Andrea L. Stevens

Andrea L. Stevens
Senior Director
Precision Medicine Access, Johnson & Johnson

Ezra Cohen

Ezra Cohen
CMO, Oncology
Tempus Labs

Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health

Michael Hodsdon

Michael Hodsdon
VP, Clinical Diagnostics Laboratory
Eli Lilly

Wendy Rubinstein

Wendy Rubinstein
Senior Scientific Officer, Cancer Prevention
NCI

Jai Pandey

Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi

Edward Abrahams

Edward Abrahams
President
Personalized Medicine Coalition

Christopher Hartshorn

Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS

Robert A. Smith

Robert A. Smith
SVP, Center for Cancer Screening
American Cancer Society

Kyle Farh

Kyle Farh
VP, Artificial Intelligence Lab
Illumina

Rajiv Raja

Rajiv Raja
Executive Director, Precision Medicine, Oncology
GSK

Shawn Carlson

Shawn Carlson
Vice President, Head of Market Access
Roche Diagnostics

Sudhir Srivastava

Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI

Key Contacts


PARTNERING AND SPONSORSHIP

Phillip Zakim-Yacouby

Companies A-K

Phillip Zakim-Yacouby
Senior Business Development Manager
Cambridge Healthtech Institute
781-247-1815
pzakim-yacouby@cambridgeinnovationinstitute.com

Katelin Fitzgerald

Companies L-Z
Katelin Fitzgerald
Sr. Manager, Business Development
Cambridge Healthtech Institute
781-247-1824
kfitzgerald@healthtech.com


Julia Boguslavsky

For meeting questions or suggestions, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

Rich Handy

For media and association partnerships, please contact:
Rich Handy
Associate Vice President, Marketing
Cambridge Healthtech Institute
781-972-5456
rhandy@healthtech.com